Pages that link to "Q37833587"
Jump to navigation
Jump to search
The following pages link to CE-MS in biomarker discovery, validation, and clinical application (Q37833587):
Displaying 46 items.
- Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products (Q28533986) (← links)
- Proteomic Analysis of Vitreous Humor in Retinal Vein Occlusion (Q28552292) (← links)
- Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications (Q31148183) (← links)
- Proteomics of vitreous humor of patients with exudative age-related macular degeneration (Q33610106) (← links)
- Biomarkers in development of psychotropic drugs. (Q33993209) (← links)
- Identification of urinary peptide biomarkers associated with rheumatoid arthritis (Q34075303) (← links)
- Global proteomics and metabolomics in cancer biomarker discovery (Q34079038) (← links)
- Toward rapid, high-sensitivity, volume-constrained biomarker quantification and validation using backscattering interferometry (Q34434036) (← links)
- Recent advances in the combination of capillary electrophoresis with mass spectrometry: from element to single-cell analysis (Q34480649) (← links)
- Protein interactome of muscle invasive bladder cancer (Q34876528) (← links)
- Oncoproteomics: Trials and tribulations (Q35827653) (← links)
- Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides (Q35903097) (← links)
- Identification of Symptomatic Fetuses Infected with Cytomegalovirus Using Amniotic Fluid Peptide Biomarkers (Q35903895) (← links)
- Mass spectrometry for diabetic nephropathy monitoring: new effective tools for physicians (Q35997377) (← links)
- Urinary proteomic profiling in severe obesity and obstructive sleep apnoea with CPAP treatment (Q36171255) (← links)
- The use of urinary proteomics in the assessment of suitability of mouse models for ageing (Q36281053) (← links)
- Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models (Q36443870) (← links)
- Ultrasensitive sample quantitation via selected reaction monitoring using CITP/CZE-ESI-triple quadrupole MS. (Q36540986) (← links)
- Identification of ageing-associated naturally occurring peptides in human urine (Q36544030) (← links)
- Capillary zone electrophoresis for bottom-up analysis of complex proteomes (Q36630922) (← links)
- Clinical application of urinary proteomics/peptidomics (Q37945790) (← links)
- Recent developments in CE and CEC of peptides (2009-2011). (Q37964561) (← links)
- Recent advances in the application of capillary electromigration methods for food analysis and Foodomics (Q37965420) (← links)
- Recent advances in the application of CE to forensic sciences, an update over years 2009-2011. (Q37972860) (← links)
- Capillary electrophoresis/mass spectrometry relevant to pharmaceutical and biotechnological applications (Q38021959) (← links)
- On-line CE/ESI/MS interfacing: recent developments and applications in proteomics (Q38034203) (← links)
- Potential biomarkers for early detection of acute graft-versus-host disease (Q38038568) (← links)
- Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications (Q38091336) (← links)
- Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer (Q38130892) (← links)
- Recent developments in capillary and microchip electroseparations of peptides (2011-2013). (Q38164318) (← links)
- Review of the CE-MS platform as a powerful alternative to conventional couplings in bio-omics and target-based applications (Q38184491) (← links)
- Proteomic urinary biomarker approach in renal disease: from discovery to implementation (Q38196316) (← links)
- Capillary zone electrophoresis on-line coupled to mass spectrometry: A perspective application for clinical proteomics (Q38340351) (← links)
- CE-MS-based proteomics in biomarker discovery and clinical application (Q38340358) (← links)
- New perspectives on bioactivity of olive oil: evidence from animal models, human interventions and the use of urinary proteomic biomarkers. (Q38549466) (← links)
- Recent progress in urinary proteome analysis for prostate cancer diagnosis and management (Q38613772) (← links)
- BcCluster: A Bladder Cancer Database at the Molecular Level (Q39634042) (← links)
- Comparison of higher energy collisional dissociation and collision-induced dissociation MS/MS sequencing methods for identification of naturally occurring peptides in human urine (Q41142978) (← links)
- Urinary proteomics in obstructive sleep apnoea and obesity. (Q48026870) (← links)
- Untargeted Screening of Urinary Peptides Using Offline Nano-Liquid Chromatography: MALDI-TOF/TOF Mass Spectrometry (Q50078073) (← links)
- Comparison of CE-MS/MS and LC-MS/MS sequencing demonstrates significant complementarity in natural peptide identification in human urine. (Q50708333) (← links)
- Identification of Metabolites Associated with Onset of CAD in Diabetic Patients Using CE-MS Analysis: A Pilot Study (Q57172545) (← links)
- Fetal Urinary Peptides to Predict Postnatal Outcome of Renal Disease in Fetuses with Posterior Urethral Valves (PUV) (Q57711889) (← links)
- How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE-MS (Q57711927) (← links)
- The Possibilities to Improve Kidney Health with Proteomics (Q88579491) (← links)
- Past, present, and future developments in enantioselective analysis using capillary electromigration techniques (Q99353317) (← links)